Posted On: 07/16/2014 5:36:08 AM
Post# of 6

NWCI Financials 07/16/2014 04:36:11
Newcardio, Inc.
Period Ending Dec 31, 2010
Total Revenue 257
Cost of Revenue 152
Gross Profit 105
Operating Expenses
Research and Development 3,585
Sales, General and Admin. 5,916
Non-Recurring Items -
Other 63
Operating Income (9,459)
Income From Continuing Operations
Add'l Income/Expense Items (1,826)
Earnings Before Interest and Tax (11,496)
Interest Expense -
Earnings Before Tax (11,496)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (11,496)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (11,496)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (11,496)
Newcardio, Inc.
Period Ending Dec 31, 2010
Total Revenue 257
Cost of Revenue 152
Gross Profit 105
Operating Expenses
Research and Development 3,585
Sales, General and Admin. 5,916
Non-Recurring Items -
Other 63
Operating Income (9,459)
Income From Continuing Operations
Add'l Income/Expense Items (1,826)
Earnings Before Interest and Tax (11,496)
Interest Expense -
Earnings Before Tax (11,496)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (11,496)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (11,496)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (11,496)

